2002
DOI: 10.1016/s0031-9422(02)00101-2
|View full text |Cite
|
Sign up to set email alerts
|

Antiplasmodial activity of sesquilignans and sesquineolignans from Bonamia spectabilis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 21 publications
2
24
0
Order By: Relevance
“…3) to prevent the transmission of T. cruzi by blood transfusion. However, some lignans have also been shown to have effects against L. donovani (Oketch-Rabah et al 1997;Barata et al 2000) and P. falciparum (OketchRabah et al 1997;Kraft et al 2002).…”
Section: Lignansmentioning
confidence: 99%
“…3) to prevent the transmission of T. cruzi by blood transfusion. However, some lignans have also been shown to have effects against L. donovani (Oketch-Rabah et al 1997;Barata et al 2000) and P. falciparum (OketchRabah et al 1997;Kraft et al 2002).…”
Section: Lignansmentioning
confidence: 99%
“…The search of new drugs against leishmaniasis, potentially compounds and their derivatives have been described in the literature. [14][15][16] Neolignans are groups of compounds that show a wide range of biological effects including antifungal, [17][18][19] anti-schistosomal, [20][21][22][23] antiplasmodial, 24 trypanocidal, [25][26][27] antibacterial, 28 anti-PAF, 29,30 antipsychotic, 31 antioxidant, 32,33 activities, and biological activity against Escherichia coli,…”
Section: Introductionmentioning
confidence: 99%
“…77 Other classes of lignans including: tetrahydrofuran lignans, neolignans, dibenzylbutanelignan and a coumarinolignan also demonstrated varying degrees of antimalarial activities against mainly P. falciparum with tetrahydrofuran-type sesquilignans revealing significant activities. [78][79][80][81][82] Compound 3 was also active against the three strains of the malaria parasite tested with IC 50 …”
Section: Bioactivity Resultsmentioning
confidence: 99%